Drug Development Applications For The Medical / Health Care Industry In USA

However, approximately 30% of drugs fail during human clinical trials due to adverse reactions despite promising preclinical study results, and another 60% fail due to lack of efficacy. As companies broaden the modality toolbox with novel drug delivery mechanisms, clinical translation becomes even more challenging. Put simply, current models do not offer the predictive value required to confidently transition drug candidates to the ...

By Emulate based in Boston, MASSACHUSETTS (USA).

While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...

By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).

High Performance Across the Breadth of Biotech. The NX One is a perfect fit for a wide variety of sectors and application areas spanning fundamental biological research to industrial and clinical workflows. Access your cells faster and at a fraction of the ...

By Nodexus Inc. based in Hayward, CALIFORNIA (USA).

Effecting an estimated one million Americans, Crohn's disease can be highly debilitating and remains a serious burden for both patients and healthcare systems. ...

By RedHill Biopharma Ltd. Office in Raleigh, NORTH CAROLINA (USA).

From accelerating drug discovery to leveraging real world evidence, Centaur Labs provides life sciences innovators with high-quality medical data annotations at unprecedented speed and ...

By Centaur Labs based in Boston, MASSACHUSETTS (USA).

Thermal Management: Pyroid HT pyrolytic graphite thermal spreaders and thermal vias are a powerful new material solution in the battle against thermal heat in state-of-the-art electronic circuits and devices. HT material matches the heat spreading capability of CVD diamond at 1700 W/mK but at substantially better economics. ...

By CETCO Office in Hoffman Estates, ILLINOIS (USA).

For more than 20 years, we have been bringing our research and expertise to this therapeutic area. We have focused on developing novel drugs in areas of unmet need, such as autosomal dominant polycystic kidney disease and hyponatremia, that have changed the treatment landscape. ...

By Otsuka America Pharmaceutical, Inc Office in Hayward, CALIFORNIA (USA).

Locus has built an automated, generalizable platform that is systematically unlocking the power of bacteriophage and CRISPR-Cas3 across multiple therapeutic ...

By Locus Biosciences, Inc. based in Morrisville, NORTH CAROLINA (USA).